Fungi

Farmmi Receives Top Ten Brand and Enterprise Awards

Retrieved on: 
Tuesday, November 19, 2019

Zhejiang Farmmi Food Co., Ltd., another subsidiary of the Company, was awarded a Top Ten Excellent Enterprise by the Zhejiang Edible Shiitake Association in November 2019.

Key Points: 
  • Zhejiang Farmmi Food Co., Ltd., another subsidiary of the Company, was awarded a Top Ten Excellent Enterprise by the Zhejiang Edible Shiitake Association in November 2019.
  • At the festival, a series of development activities, including training, data exchanges, product exhibitions, and sales and brand promotion discussions were held.
  • The goal of the festival was to promote the transformation and to accelerate the expansion of the edible mushroom industry in China.
  • Everything we stress, including our commitment to high-quality and technological innovation, goes into the development of our strong brands and product offerings.

Biofungicide World Markets to 2024 - A $2.87 Billion Industry Opportunity

Retrieved on: 
Wednesday, October 23, 2019

Dublin, Oct. 23, 2019 (GLOBE NEWSWIRE) -- The "Global Biofungicide Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Dublin, Oct. 23, 2019 (GLOBE NEWSWIRE) -- The "Global Biofungicide Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
  • The global biofungicide market was valued at USD 1,208.2 million in 2018, and it is projected to reach a value of USD 2,877.2 million by 2024, growing at a CAGR of 15.6% during the forecast period.
  • The restraints identified in the market are high target pest specificity, lower shelf life and lack of awareness of bioinputs.
  • In countries like Canada and the United States, Trichoderma harzianum strain T-22 is the most commercially used biofungicide.

Matinas BioPharma Initiates EnACT Study of MAT2203 (Oral Amphotericin B) for the Treatment of Fungal Cryptococcal Meningitis

Retrieved on: 
Monday, October 14, 2019

We are extremely pleased to advance clinical development of MAT2203 for the treatment of cryptococcal meningitis, commented Theresa Matkovits, Ph.D., Chief Development Officer of Matinas.

Key Points: 
  • We are extremely pleased to advance clinical development of MAT2203 for the treatment of cryptococcal meningitis, commented Theresa Matkovits, Ph.D., Chief Development Officer of Matinas.
  • This trial utilizes MAT2203, which applies the Companys LNC drug delivery technology to orally deliver amphotericin B, an otherwise IV-only, highly toxic, fungicidal drug for the treatment of HIV-patients with cryptococcal meningitis.
  • Part 2 is a prospective randomized trial evaluating the safety, tolerability and efficacy of MAT2203 in HIV-infected patients with cryptococcal meningitis, compared to treatment with standard IV-administered amphotericin B as induction therapy.
  • In addition, the Company is developing MAT2203, an oral, encochleated formulation of amphotericin B, to treat serious invasive fungal infections.

Matinas BioPharma Receives Orphan Drug Designation From U.S. FDA for MAT2203 for the Treatment of Cryptococcosis

Retrieved on: 
Monday, October 7, 2019

MAT2203 is Matinas orally-administered formulation of the broad-spectrum fungicidal medication amphotericin B, which is currently in Phase 2 clinical development.

Key Points: 
  • MAT2203 is Matinas orally-administered formulation of the broad-spectrum fungicidal medication amphotericin B, which is currently in Phase 2 clinical development.
  • This novel mechanism of delivery has the potential to make MAT2203 an important and valuable treatment for invasive fungal infections like cryptococcal meningitis, which is within the scope of this FDA-granted orphan drug designation.
  • Adding orphan drug designation to the QIDP for the treatment of cryptococcal meningitis potentially positions MAT2203 for up to 12 years of marketing exclusivity, if approved.
  • The FDA grants orphan drug designation to novel drugs or biologics that treat rare diseases or conditions affecting fewer than 200,000 patients in the U.S.

Amplyx Announces Presentations on Fosmanogepix (APX001) at IDWeek 2019 and the 9th Congress on Trends in Medical Mycology (TIMM-9)

Retrieved on: 
Tuesday, September 24, 2019

Presenter: Nathan P. Wiederhold, PharmD., Professor, University of Texas Health San Antonio, San Antonio, TX

Key Points: 
  • Presenter: Nathan P. Wiederhold, PharmD., Professor, University of Texas Health San Antonio, San Antonio, TX
    Full abstracts can be accessed through the IDWeek website.
  • Manogepix (APX001A), the active moiety of fosmanogepix (APX001), inhibits the highly conserved fungal enzyme Gwt1, compromising growth of fungal pathogens.
  • In multiple nonclinical studies, manogepix has shown broad-spectrum activity against common species ofCandida andAspergillus, including multi-drug resistant strains, such asC.
  • Amplyx Pharmaceuticals is focused on developing innovative therapies for patients with compromised immune systems, including cancer and transplant patients, and the critically ill.

YIELD GROWTH Enters into Agreement to Acquire a 30% interest in Mushroom Business One Up Pure Energy, and is engaged for its Going Public Transaction

Retrieved on: 
Tuesday, September 17, 2019

Yield Growth also entered into a consultancy agreement with Absolem to provide corporate finance and other services to assist the company with a going public transaction.

Key Points: 
  • Yield Growth also entered into a consultancy agreement with Absolem to provide corporate finance and other services to assist the company with a going public transaction.
  • "As these medicinal mushroom extracts gain popularity, they are mainly available as powdered extracts, capsules and drink mixes.
  • "Our research indicates that edible mushrooms are in a period of high growth," says Yield Growth CEO Penny White.
  • Yield Growth has also signed an Advisory Agreement to provide various services including bookkeeping, project management and corporate communications.

Global cryptococcosis market is expected to grow with a CAGR of 5.1% over the forecast period from 2019-2025

Retrieved on: 
Tuesday, June 18, 2019

NEW YORK, June 18, 2019 /PRNewswire/ -- The report on the global cryptococcosis market provides qualitative and quantitative analysis for the period from 2017 to 2025.

Key Points: 
  • NEW YORK, June 18, 2019 /PRNewswire/ -- The report on the global cryptococcosis market provides qualitative and quantitative analysis for the period from 2017 to 2025.
  • The report predicts the global cryptococcosis market to grow with a CAGR of 5.1% over the forecast period from 2019-2025.
  • The study on cryptococcosis market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.
  • The report on cryptococcosis market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cryptococcosis market over the period of 2017 to 2025.

Get Ready to Take a Trip: Quiznos’ Magic Mushroom Melt Gets its Groove On at Downtown Denver Location on June 22

Retrieved on: 
Monday, June 17, 2019

Downtown Denver is set to get gooey and groovy as Quiznos unveils a new Magic Mushroom Melt for one day only at its 1275 Grant Street location on Saturday, June 22, 2019.

Key Points: 
  • Downtown Denver is set to get gooey and groovy as Quiznos unveils a new Magic Mushroom Melt for one day only at its 1275 Grant Street location on Saturday, June 22, 2019.
  • View the full release here: https://www.businesswire.com/news/home/20190617005056/en/
    Quiznos' Magic Mushroom Melt (Photo: Business Wire)
    The first 50 customers who line up for this ultimate tasty trip will receive a custom Magic Mushroom Melt t-shirt and a Quiznos gift card.
  • While the Magic Mushroom Melt looks psychedelic, the only truly mind-bending elements are its fabulous flavor and artistic design.
  • The limited time only Magic Mushroom Melt will be served to customers at the 1275 Grant Street Quiznos as long as supplies last on Saturday, June 22, 2019.

Mushroom Market to Breach US$ 69 Bn Mark by 2024; Increased Demand for Processed Food Augurs Well for Future - TMR

Retrieved on: 
Wednesday, June 5, 2019

As a result, the emergence of key entrants in the mushroom market is expected to be convenient in regional and global market.

Key Points: 
  • As a result, the emergence of key entrants in the mushroom market is expected to be convenient in regional and global market.
  • Request a Sample of Global Mushroom Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    Based on form, the global mushroom market is bifurcated as processed mushroom and fresh mushroom.
  • Among these, the fresh mushroom segment held a lead of 56.5%, of share of global mushroom market in 2016.
  • The study presented here is based on a report by Transparency Market Research (TMR) titled "Mushroom Market (Type - Button Mushroom, Shiitake Mushroom, and Oyster Mushroom; Form - Fresh Mushroom and Processed Mushroom (Dried Mushroom, Frozen Mushroom, and Canned Mushroom); End Use - Food Processing Industry, Retail Outlets, and Food Service) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 2024."

Mushroom Market to Breach US$ 69 Bn Mark by 2024; Increased Demand for Processed Food Augurs Well for Future - TMR

Retrieved on: 
Wednesday, June 5, 2019

As a result, the emergence of key entrants in the mushroom market is expected to be convenient in regional and global market.

Key Points: 
  • As a result, the emergence of key entrants in the mushroom market is expected to be convenient in regional and global market.
  • Request a Sample of Global Mushroom Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    Based on form, the global mushroom market is bifurcated as processed mushroom and fresh mushroom.
  • Among these, the fresh mushroom segment held a lead of 56.5%, of share of global mushroom market in 2016.
  • The study presented here is based on a report by Transparency Market Research (TMR) titled "Mushroom Market (Type - Button Mushroom, Shiitake Mushroom, and Oyster Mushroom; Form - Fresh Mushroom and Processed Mushroom (Dried Mushroom, Frozen Mushroom, and Canned Mushroom); End Use - Food Processing Industry, Retail Outlets, and Food Service) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 2024."